About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSMS Pharmaceuticals Limited10.421490807134.0390
Domestic EquitiesANTHEM BIOSCIENCES LIMITED9.292646250930.3522
Domestic EquitiesAster DM Healthcare Limited9.162544667129.9270
Domestic EquitiesZydus Wellness Ltd8.376664173027.3602
Domestic EquitiesSequent Scientific Limited8.3287148799727.2036
Domestic EquitiesAlivus Life Sciences7.334824629823.9574
Domestic EquitiesPfizer Ltd6.93054795422.6367
Domestic EquitiesAurobindo Pharma Limited5.203613030016.9963
Domestic EquitiesICICI Prudential Life Insurance Co Ltd4.642529759115.1637
Domestic EquitiesHDFC Life Insurance Co Ltd4.117222770013.4480
Domestic EquitiesMedplus Health Services Limited3.859015007112.6045
Domestic EquitiesConcord Biotech Limited2.6026834728.5008
Domestic EquitiesGlaxosmithkline Pharmaceuticals Ltd2.2715324987.4193
Domestic EquitiesGland Pharma Limited1.4579280764.7620
Domestic EquitiesAdani Enterprises Limited0.6138113992.0049
Total 84.6152 276.3756
Cash & Cash Equivalents and Net AssetsTREPS 02-Apr-2026 DEPO 109.16172993429.9246
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-15.7998 -51.6064
Total -6.6381 -21.6818
Treasury Bills91 Days Treasury Bill 22-May-20261.82326000005.9550
Treasury Bills91 Days Treasury Bill 23-Apr-20260.91543000002.9900
Treasury Bills91 Days Treasury Bill 30-Apr-20260.91453000002.9871
Treasury Bills91 Days Treasury Bill 07-May-20260.91353000002.9838
Treasury Bills91 Days Treasury Bill 14-May-20260.91273000002.9811
Treasury Bills91 Days Treasury Bill 04-Jun-20260.90973000002.9714
Treasury Bills91 Days Treasury Bill 17-Apr-20260.30541000000.9975
Total 6.6945 21.8659
Derivatives-FuturesAurobindo Pharma Limited 28/04/20264.025710065013.1489
Derivatives-FuturesHDFC Life Insurance Co Ltd 28/04/20263.974221890012.9808
Derivatives-FuturesBiocon Ltd 28/04/20263.822034500012.4838
Derivatives-FuturesDr. Reddy's Laboratories Limited 28/04/20261.8819487506.1469
Derivatives-FuturesICICI Prudential Life Insurance Co Ltd 28/04/20261.62461036005.3064
Total 15.3285 50.0668
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.